Nicole Borsje | Investor Relations |
Ming Hsieh | Chief Executive Officer |
Brandon Perthuis | Chief Commercial Officer |
Paul Kim | Chief Financial Officer |
Larry Weiss | Chief Medical Officer |
Kevin DeGeeter | Oppenheimer. |
Sung Ji Nam | BTIG |
David Westenberg | Piper Sandler |
Good day and welcome to the Fourth Quarter 2021 Fulgent Genetics Earnings Conference Call. Today's conference is being recorded. At this time, I would like to turn the conference over to Nicole Borsje with Investor Relations. Please go ahead.
Thank you.